| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 84151 |
cas:2259318-50-6，MA-PEG4-VA-PBD ， ADC试剂 |
218 |
kx |
2024-12-19 |
| 84152 |
CAS: 2259318-55-1 - DBCO-(PEG2-VC-PAB-MMAE)2 |
109 |
WYQ |
2024-12-19 |
| 84153 |
CAS: 2768446-73-5，DBCO-Val-Cit-PAB-MMAE |
140 |
WYQ |
2024-12-19 |
| 84154 |
MC-vc-PAB-C6-a-amanitin， ADC试剂 |
143 |
kx |
2024-12-19 |
| 84155 |
cas:663598-98-9，2,5-dioxopyrrolidin-1-yl 4-methyl-4-((5-nitropyridin-2-yl)disulfanyl)pentanoate，ADC定制 |
143 |
wyh |
2024-12-19 |
| 84156 |
cas:2873452-49-2 MC-EVCit-PAB-MMAE |
148 |
zyl |
2024-12-19 |
| 84157 |
2,5-dioxopyrrolidin-1-yl 3-methyl-3-(pyridin-2-yldisulfanyl)butanoate，ADC定制 |
169 |
wyh |
2024-12-19 |
| 84158 |
cas:159857-70-2 MC-Val-Cit-Doxorubicin |
168 |
zyl |
2024-12-19 |
| 84159 |
Gly3-vc-PAB-MMAE， ADC试剂 |
184 |
kx |
2024-12-19 |
| 84160 |
CAS: 1869126-64-6， Azido-PEG4-Val-Cit-PAB-MMAE |
155 |
WYQ |
2024-12-19 |
| 84161 |
cas:2353409-54-6 ， Mal-amido-PEG8-Val-Gly，ADC定制 |
177 |
wyh |
2024-12-19 |
| 84162 |
Azido-PEG4-Val-Ala-PAB-PNP |
175 |
zyl |
2024-12-19 |
| 84163 |
NOTA-(NGR)2 NOTA偶联NGR二聚体 |
137 |
h |
2024-12-19 |
| 84164 |
1-(2,5-dioxopyrrolidin-1-yloxy)-4-((5-nitropyridin-2-yl)disulfanyl)-1-oxobutane-2-sulfonic acid，ADC定制 |
128 |
wyh |
2024-12-19 |
| 84165 |
CAS: 1343476-44-7，Val-Ala-PAB-OH |
127 |
WYQ |
2024-12-19 |
| 84166 |
MC-PBD， ADC试剂 |
158 |
kx |
2024-12-19 |
| 84167 |
Mal-Val-Ala-PAB的介绍 |
167 |
zyl |
2024-12-19 |
| 84168 |
DOTA-K-A9 1,4,7,10-四氮杂环十二烷-N,N,N,N-四乙酸(DOTA)结合肽A9 |
147 |
h |
2024-12-19 |
| 84169 |
Azide-PEG3-Val-Cit-PAB-MMAF，叠氮-三聚乙二醇-Val-Cit-PAB-MMAF |
143 |
WYQ |
2024-12-19 |
| 84170 |
Arm-DOTA-B72.3 |
146 |
h |
2024-12-19 |
| 84171 |
cas:1884577-99-4 Boc-Val-Ala-PAB |
156 |
zyl |
2024-12-19 |
| 84172 |
(Lys(DOTA)4)BVD15 DOTA偶联神经肽Y(NPY)类似物 |
227 |
h |
2024-12-19 |
| 84173 |
1801838-28-7，Mc-vc-PAB-SN38，化合物MC-VC-PAB-SN38 |
151 |
kx |
2024-12-19 |
| 84174 |
DOTA-PPI 1,4,7,10-四氮杂环十二烷-N,N,N,N-四乙酸(DOTA)-官能化的聚(丙烯亚胺)(PPI)糖树枝状分子 |
153 |
h |
2024-12-19 |
| 84175 |
CAS: 863971-17-9，MC-Val-Cit-PAB-MMAF |
165 |
WYQ |
2024-12-19 |
| 84176 |
cas:1884577-99-4 Boc-Val-Ala-PAB |
187 |
zyl |
2024-12-19 |
| 84177 |
DBCO-PEG4-vc-PAB-MMAE， ADC试剂 |
181 |
kx |
2024-12-19 |
| 84178 |
1884578-00-0，Boc-PEG4-Val-Ala-PAB-PNP，ADC定制 |
173 |
wyh |
2024-12-19 |
| 84179 |
DOTA-Peg-Cpa-c[DCys-Aph(Cbm)-DTrp-Lys-Thr-Cys]-2Nal-NH2 |
145 |
h |
2024-12-19 |
| 84180 |
DOTA-2.5D DOTA-胱氨酸结肽(knottins)2.5D和2.5F |
179 |
h |
2024-12-19 |
| 84181 |
二苯并环辛炔-四聚乙二醇-VAL-ALA-PAB，ADC定制 |
164 |
wyh |
2024-12-19 |
| 84182 |
Hz220(DOTA-Lys(IR dye 650)-PEa(4)-[D-Phe(6)DOTA偶联的GRPr拮抗剂 |
160 |
h |
2024-12-19 |
| 84183 |
Azido-PEG4-MMAE，抗体药物偶联物（ADCs） |
184 |
WYQ |
2024-12-19 |
| 84184 |
1626359-62-3，SPDB-DM4， ADC试剂 |
137 |
kx |
2024-12-19 |
| 84185 |
Acid-PEG4-Val-Cit-PAB-MMAE，包含PEG链和MMAE等部分 |
165 |
WYQ |
2024-12-19 |
| 84186 |
cas:159857-70-2，MC-Val-Cit-Doxorubicin，ADC定制 |
157 |
wyh |
2024-12-19 |
| 84187 |
DOTA-(D)Phe(1)-Tyr(3) |
147 |
h |
2024-12-19 |
| 84188 |
cas:1884577-99-4 Boc-Val-Ala-PAB |
183 |
zyl |
2024-12-19 |
| 84189 |
FAM-amido hexamethylene carbamate-PAB-Cit-Val-Alkyne |
196 |
WYQ |
2024-12-19 |
| 84190 |
DOTA-l-Nal3-octreotide DOTA-l-nal3-奥曲肽 |
153 |
h |
2024-12-19 |
| 84191 |
CAS: 2762518-86-3 ，NHS ester-PEG4-Val-Cit-PAB-MMAE |
163 |
WYQ |
2024-12-19 |
| 84192 |
cas:2873452-49-2 ； MC-EVCit-PAB-MMAE，ADC定制 |
175 |
wyh |
2024-12-19 |
| 84193 |
CAS: 2762519-08-2 endo-BCN-PEG4-Val-Cit-PAB-MMAE，内末端二苯卡宾吡啶甲酸乙酯聚乙二醇4个单元赖氨酸缬氨酸丙氨酸天冬氨酸 |
185 |
WYQ |
2024-12-19 |
| 84194 |
cas:863971-24-8，Mc-MMAE ，马来酰亚胺基己酰-单甲基澳瑞他汀 E |
219 |
kx |
2024-12-19 |
| 84195 |
DOTA-(AEEA)2-BN DOTA-(AEEA)2-铃蟾肽 |
170 |
h |
2024-12-19 |
齐岳微信公众号
官方微信
库存查询